In addition, EZH2 promotes epithelial-mesenchymal transition (EMT), a process that is associated with cancer progression and metastasis, by interacting with transcription factor SNAIL1 and suppressing expression of epithelial marker E-cadherin (CDH1). This evidence concerns the gene SNAI1 and cancer.